NCT04338204 - Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

August 14, 2026

Study Completion Date

August 14, 2026

Conditions

Ulcerative Colitis

Interventions

DRUG

tofacitinib

Observational study

Trial Locations (17)

11486

ACTIVE_NOT_RECRUITING

Stockholm Gastro Center, Stockholm

11691

ACTIVE_NOT_RECRUITING

Ersta Sjukhus, Medicinkliniken, Fjällgatan 44, Stockholm

17176

ACTIVE_NOT_RECRUITING

Karolinska Universitetssjukhuset i Solna, Eugeniavägen 3, B4-09,, Stockholm

18257

ACTIVE_NOT_RECRUITING

Danderyds Hospital, Stockholm

20501

ACTIVE_NOT_RECRUITING

Region skåne, Skånes Universitetssjukhus, Malmo

29185

RECRUITING

Daniel Molin, Kristianstad

50985

ACTIVE_NOT_RECRUITING

Medicinkliniken, Umeås Universitetssjukhus, Umeå

55185

ACTIVE_NOT_RECRUITING

Medicinkliniken, Länssjukhuset Ryhov, Sjukhusgatan, Jönköping

58185

ACTIVE_NOT_RECRUITING

Mag-Tarmmedicinska kliniken, Universitetssjukhuset i Linköping, Linköping

70185

ACTIVE_NOT_RECRUITING

Medicinmottagning 4, Medicinska Kliniken, Universitetssjukhuset Örebro, Örebro

72189

ACTIVE_NOT_RECRUITING

Medicinmottagningen gastroenterologi, Västmanlands sjukhus, Västerås

75185

ACTIVE_NOT_RECRUITING

Specialmedicin, Akademiska Sjukhuset, Sjukhusvägen ing 40, Uppsala

80324

ACTIVE_NOT_RECRUITING

Gävle Hospital, Gävle

SE-441 33

ACTIVE_NOT_RECRUITING

Ulf Eriksson, Alingsås

Unknown

ACTIVE_NOT_RECRUITING

Medicinkliniken, Södra Älvsborgs Sjukhus Borås, Brämhultsvägen 53, Borås

ACTIVE_NOT_RECRUITING

Shiprock Consulting AB,, Lidingö

Göteborg

ACTIVE_NOT_RECRUITING

SU/Sahlgrenska, Gastroenterologi & Hepatologi, Gothenburg